The mechanisms that regulate ubiquitin-mediated degradation of proteins such as the mitotic cyclins at defined stages of the cell cycle are poorly understood. The initial step in the conjugation of ubiquitin to substrate proteins involves the activation of ubiquitin by the ubiquitin-activating enzyme, E1. Previously we have described the subcellular localization of this enzyme to both nuclear and cytoplasmic compartments. In the present study, we have used the 1C5 anti-E1 monoclonal antibody in immunofluorescent-microscopy and subcellular-fractionation techniques to examine the distribution of E1 during the HeLa cell cycle. E1 is both cytoskeletal and nuclear during the G1-phase. As the cells progress into S-phase, E1 is exclusively cytoskeletal and has a perinuclear distribution. During G2-phase, E1 reappears in the nucleus before breakdown of the nuclear envelope. In mitotic cells, E1 localizes to both the mitotic spindle and the cytosol, but is absent from the chromosomes. Immunoblot analysis reveals multiple forms of E1 in HeLa whole cell extract. This heterogeneity is not a result of polyubiquitination and may represent inactive pools of E1. Only the characteristic E1 doublet is able to activate ubiquitin. Cell-fractionation studies reveal a differential distribution of specific E1 isoforms throughout the cell cycle. Therefore we propose that the subcellular localization of E1 may play a role in regulating cell-cycle-dependent conjugation of ubiquitin to target proteins.
Skip Nav Destination
Follow us on Twitter @Biochem_Journal
Article navigation
June 1994
-
Cover Image
Cover Image
- PDF Icon PDF LinkFront Matter
- PDF Icon PDF LinkTable of Contents
- PDF Icon PDF LinkAdvertising
Research Article|
June 15 1994
Nuclear localization of the ubiquitin-activating enzyme, E1, is cell-cycle-dependent
S J Grenfell;
S J Grenfell
*Edward Mallinckrodt Departments of Pediatrics and Pharmacology, Washington University School of Medicine and Division of Pediatric Hematology-Oncology, Children's Hospital, St. Louis, MO 63110, U.S.A
Search for other works by this author on:
J S Trausch-Azar;
J S Trausch-Azar
*Edward Mallinckrodt Departments of Pediatrics and Pharmacology, Washington University School of Medicine and Division of Pediatric Hematology-Oncology, Children's Hospital, St. Louis, MO 63110, U.S.A
Search for other works by this author on:
P M Handley-Gearhart;
P M Handley-Gearhart
*Edward Mallinckrodt Departments of Pediatrics and Pharmacology, Washington University School of Medicine and Division of Pediatric Hematology-Oncology, Children's Hospital, St. Louis, MO 63110, U.S.A
Search for other works by this author on:
A Ciechanover;
A Ciechanover
†nit of Biochemistry and Rappaport Institute for Research in the Medical Sciences, Faculty of Medicine, Technion-Israel Institute of Technology, Haifa 31096, Israel
Search for other works by this author on:
A L Schwartz
A L Schwartz
*Edward Mallinckrodt Departments of Pediatrics and Pharmacology, Washington University School of Medicine and Division of Pediatric Hematology-Oncology, Children's Hospital, St. Louis, MO 63110, U.S.A
Search for other works by this author on:
Publisher: Portland Press Ltd
Online ISSN: 1470-8728
Print ISSN: 0264-6021
© 1994 The Biochemical Society, London
1994
Biochem J (1994) 300 (3): 701–708.
Citation
S J Grenfell, J S Trausch-Azar, P M Handley-Gearhart, A Ciechanover, A L Schwartz; Nuclear localization of the ubiquitin-activating enzyme, E1, is cell-cycle-dependent. Biochem J 15 June 1994; 300 (3): 701–708. doi: https://doi.org/10.1042/bj3000701
Download citation file:
Sign in
Don't already have an account? Register
Sign in to your personal account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Biochemical Society Member Sign in
Sign InSign in via your Institution
Sign in via your InstitutionGet Access To This Article
Follow us on Twitter @Biochem_Journal
Open Access for all
We offer compliant routes for all authors from 2025. With library support, there will be no author nor reader charges in 5 journals. Check here |
![]() View past webinars > |